Surgery Partners Inc

$ 15.31

2.48%

12 Jun - close price

  • Market Cap 2,002,367,000 USD
  • Current Price $ 15.31
  • High / Low $ 15.33 / 14.80
  • Stock P/E N/A
  • Book Value 13.03
  • EPS -0.59
  • Next Earning Report 2026-08-04
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA 0.04 %
  • ROE 0.03 %
  • 52 Week High 24.10
  • 52 Week Low 11.41

About

Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company is headquartered in Brentwood, Tennessee.

Analyst Target Price

$17.95

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-05-052026-03-022025-11-102025-08-052025-05-122025-03-032024-11-122024-08-062024-05-072024-02-262023-11-072023-08-01
Reported EPS -0.280.12-0.180.17-0.30.440.190.210.10.440.190.28
Estimated EPS -0.280.30380.090.14-0.080.37690.260.20.080.380.150.08
Surprise 0-0.1838-0.270.03-0.220.0631-0.070.010.020.060.040.2
Surprise Percentage 0%-60.5003%-300%21.4286%-275%16.7418%-26.9231%5%25%15.7895%26.6667%250%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-08-04
Fiscal Date Ending 2026-06-30
Estimated EPS -0.03
Currency USD

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: SGRY

Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal

2026-06-11 09:39:19

Surgery Partners' stock fell 13% after its board rejected a take-private offer from Bain Capital at $13.50 per share, deeming the proposal to significantly undervalue the company. The private equity firm, already holding a 48% stake, had initially made the offer in December. Following the rejection, Bain Capital stated it does not plan to pursue the acquisition further at this time.

...
Surgery Partners vs. Viemed Healthcare: Outpatient Facilities or Home-Based Care in 2026

2026-06-10 19:09:15

This article compares Surgery Partners (SGRY) with Viemed Healthcare (VMD), offering insights for investors into two distinct healthcare models: large-scale outpatient facilities and home-based care. Surgery Partners, operating numerous surgical centers, focuses on expanding its presence, leading to revenue growth but short-term net deficits in 2025. Viemed Healthcare specializes in in-home respiratory treatment, showing strong revenue growth and profitability in the same period by catering to the elderly and those with chronic respiratory conditions.

[Form 4] Surgery Partners, Inc. Insider Trading Activity

2026-06-10 00:40:36

This article details an insider trading activity for Surgery Partners, Inc. (SGRY) filed on a Form 4. The report indicates that insider HENDRIX BLAIR E acquired 11,670 shares of common stock at $13.71, valued at approximately $160K, with shares vesting on June 5, 2027. Following this transaction, Hendrix Blair E now directly owns 18,531 shares of common stock.

Director Laura Forese awarded 11,670 Surgery Partners (SGRY) shares as equity grant

2026-06-09 20:28:18

Director Laura L. Forese of Surgery Partners (SGRY) was awarded 11,670 shares of common stock as an equity grant, valued at a reference price of $13.71 per share. These shares are compensation related and will vest on June 5, 2027. Following this grant, her direct holdings in the company amount to 18,531 shares.

Surgery Partners (SGRY) grants 11,670-share stock award to director

2026-06-09 20:28:18

Surgery Partners (SGRY) director Dean Lloyd H was granted 11,670 shares of common stock as equity compensation, valued at $13.71 per share. This transaction was reported in a Form 4 SEC filing, indicating the shares are directly held and are scheduled to vest on June 5, 2027. Following this award, his direct holdings in Surgery Partners amount to 11,670 shares.

Director John Deane receives 11,670 Surgery Partners (SGRY) share grant

2026-06-09 20:28:17

John A. Deane, a director at Surgery Partners, Inc. (SGRY), has been granted 11,670 shares of Common Stock as equity compensation. These shares are valued at $13.71 each and are set to vest on June 5, 2027. Following this grant, Deane directly holds 45,922 shares of the company.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi